Page last updated: 2024-08-23

dexetimide and Alzheimer Disease

dexetimide has been researched along with Alzheimer Disease in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barnden, LR; Boundy, KL; Katsifis, AG; Rowe, CC	1
Booij, J; Claus, JJ; de Munck, JC; Dubois, EA; Habraken, J; van Herk, M; van Royen, EA; Verbeeten, B	1

Other Studies

2 other study(ies) available for dexetimide and Alzheimer Disease

Article	Year
Reduced posterior cingulate binding of I-123 iodo-dexetimide to muscarinic receptors in mild Alzheimer's disease. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2005, Volume: 12, Issue:4 Topics: Alzheimer Disease; Brain Mapping; Case-Control Studies; Dexetimide; Female; Follow-Up Studies; Gyrus Cinguli; Humans; Iodine Isotopes; Male; Muscarinic Antagonists; Receptors, Muscarinic; Severity of Illness Index; Tomography, Emission-Computed, Single-Photon	2005
Demonstration of a reduction in muscarinic receptor binding in early Alzheimer's disease using iodine-123 dexetimide single-photon emission tomography. European journal of nuclear medicine, 1997, Volume: 24, Issue:6 Topics: Aged; Alzheimer Disease; Brain; Case-Control Studies; Dexetimide; Female; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Muscarinic Antagonists; Observer Variation; Receptors, Muscarinic; Tomography, Emission-Computed, Single-Photon	1997

Article

Year

Reduced posterior cingulate binding of I-123 iodo-dexetimide to muscarinic receptors in mild Alzheimer's disease.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2005, Volume: 12, Issue:4

Topics: Alzheimer Disease; Brain Mapping; Case-Control Studies; Dexetimide; Female; Follow-Up Studies; Gyrus Cinguli; Humans; Iodine Isotopes; Male; Muscarinic Antagonists; Receptors, Muscarinic; Severity of Illness Index; Tomography, Emission-Computed, Single-Photon

2005

Demonstration of a reduction in muscarinic receptor binding in early Alzheimer's disease using iodine-123 dexetimide single-photon emission tomography.

European journal of nuclear medicine, 1997, Volume: 24, Issue:6

Topics: Aged; Alzheimer Disease; Brain; Case-Control Studies; Dexetimide; Female; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Muscarinic Antagonists; Observer Variation; Receptors, Muscarinic; Tomography, Emission-Computed, Single-Photon

1997